UNSPSC 85601874: Bypass ascending colon to cutaneous via natural or artificial opening synthetic substitute, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass ascending colon to cutaneous via natural or artificial opening synthetic substitute, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0D1K8J4

UNSPSC 85601874 Bypass ascending colon to cutaneous via natural or artificial opening synthetic substitute, via natural or artificial opening endoscopic is a Commodity code that does not align with the state and local procurement activity tagged under it. The recent opportunities show no purchases of medical devices, surgical implants, or related medical supplies matching the code's nominal scope. Instead, the solicitations describe administrative health services (independent medical evaluations, pharmacy benefit management, occupational medical surveillance, temporary clinical staffing), bundled surgical benefit programs, and youth detention healthcare coordination — none of which involve the specific medical device or procedure pathway the code describes. The mismatch between code taxonomy and actual procurement signals either miscoding by the issuing jurisdictions or an outdated code assignment in the sourcing system.

Recent activity across the tagged opportunities spans Arizona (City of Phoenix Retirement Office), California (City of Long Beach and County of Santa Clara Health System), Washington (Washington State Department of Transportation), Florida (Collier County Board of County Commissioners), and Texas (Harris County Juvenile Probation Department), with representative solicitations including the City of Phoenix's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026) and Collier County's RFP for pharmacy benefit management services (RFP 25-8414, $8.7 million historical annual spend). The code shows no relevant procurement activity and does not merit pursuit under its stated taxonomy.